NEW YORK (GenomeWeb News) — Jefferies Broadview investment bank has raised the price target for Applied Biosystems’ shares to a $38 a share.
As GenomeWeb News reported yesterday, ABI said fiscal first quarter revenues increased 15 percent as profit turned to a loss.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.